Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Michael A Blazing"'
Autor:
Nishant P. Shah, Darren K. McGuire, Christopher P. Cannon, Robert P. Giugliano, Yuliya Lokhnygina, Courtney B. Page, Andrew M. Tershakovec, Eugene Braunwald, Michael A. Blazing
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 13 (2023)
Externí odkaz:
https://doaj.org/article/569161cd48b54a9b83b492bbf5595815
Autor:
Christopher B. Fordyce, Robert P. Giugliano, Christopher P. Cannon, Matthew T. Roe, Abhinav Sharma, Courtney Page, Jennifer A. White, Yuliya Lokhnygina, Eugene Braunwald, Michael A. Blazing
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Unlike patients with low ejection fraction after an acute coronary syndrome (ACS), little is known about the long‐term incidence and influence of cardiovascular events before sudden death among stabilized patients after ACS. Methods and
Externí odkaz:
https://doaj.org/article/2daeb05042684ef589f10e4b38d93ba2
Autor:
Robert P. Giugliano, MD, SM, Baris Gencer, MD, Stephen D. Wiviott, MD, Jeong-Gun Park, PHD, Charles S. Fuchs, MD, MPH, Wolfram Goessling, MD, PHD, Thomas A. Musliner, MD, Andrew M. Tershakovec, MD, MPH, Michael A. Blazing, MD, Robert Califf, MD, Christopher P. Cannon, MD, Eugene Braunwald, MD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 385-396 (2020)
Background: An increased risk of malignancy was reported with simvastatin/ezetimibe in 1,873 patients in the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) trial. Objectives: The purpose of this study was to clarify this unexpected finding in a
Externí odkaz:
https://doaj.org/article/e7361de870fb47f0bb0bb5a141f13c54
Autor:
Siddharth M. Patel, Arman Qamar, Robert P. Giugliano, Petr Jarolim, Nicholas A. Marston, Jeong-Gun Park, Michael A. Blazing, Christopher P. Cannon, Eugene Braunwald, David A. Morrow
Publikováno v:
JAMA cardiology. 7(12)
ImportanceStudies have demonstrated an association between single measures of high-sensitivity troponin (hsTn) and future cardiovascular events in patients with chronic coronary syndromes. However, limited data exist regarding the association between
Autor:
Eri Toda Kato, David A Morrow, Jianping Guo, David D Berg, Michael A Blazing, Erin A Bohula, Marc P Bonaca, Christopher P Cannon, James A de Lemos, Robert P Giugliano, Petr Jarolim, Tibor Kempf, L Kristin Newby, Michelle L O’Donoghue, Marc A Pfeffer, Nader Rifai, Stephen D Wiviott, Kai C Wollert, Eugene Braunwald, Marc S Sabatine
Publikováno v:
European Heart Journal. 44:293-300
Aims Levels of growth differentiation factor 15 (GDF-15), a cytokine secreted in response to cellular stress and inflammation, have been associated with multiple types of cardiovascular (CV) events. However, its comparative prognostic performance acr
Autor:
Vishal N. Rao, Michelle D. Kelsey, Michael A. Blazing, Neha J. Pagidipati, Terry A. Fortin, Marat Fudim
Publikováno v:
Circ Heart Fail
Autor:
Marc S. Sabatine, Robert P. Giugliano, Jeong-Gun Park, Christopher P. Cannon, Michael A. Blazing, Andrew M. Tershakovec, Eugene Braunwald, Kazuma Oyama
Publikováno v:
Journal of the American College of Cardiology. 78:1499-1507
Background The 2018 U.S. cholesterol management guideline recommends additional lipid-lowering therapy with ezetimibe for secondary prevention in very high-risk patients with low-density l...
Autor:
Vishal N. Rao, Anand Shah, Jaime McDermott, Stephanie G. Barnes, Evan M. Murray, Michelle D. Kelsey, Stephen J. Greene, Marat Fudim, Adam D. DeVore, Chetan B. Patel, Michael A. Blazing, Cara O'Brien, Robert J. Mentz
Publikováno v:
Circulation: Heart Failure.
Background: Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) improves clinical outcomes and quality of life. Optimizing GDMT in the hospital is associated with greater long-term use in HFrEF. This stu
Autor:
Eri Toda Kato, Christopher P. Cannon, Michael A. Blazing, Erin Bohula, Sema Guneri, Jennifer A. White, Sabina A. Murphy, Jeong‐Gun Park, Eugene Braunwald, Robert P. Giugliano
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 11 (2017)
BackgroundIMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) showed that adding the nonstatin ezetimibe to statin therapy further reduced cardiovascular events in patients after an acute coronary syndrome. In a prespe
Externí odkaz:
https://doaj.org/article/3cd3e312a3d646ef9210b53bcd636e23
Autor:
Alexander C. Fanaroff, Matthew T. Roe, Robert M. Clare, Yuliya Lokhnygina, Ann Marie Navar, Robert P. Giugliano, Stephen D. Wiviott, Andrew M. Tershakovec, Eugene Braunwald, Michael A. Blazing
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 9 (2017)
BackgroundUnderstanding the relative risk of cardiovascular versus noncardiovascular death is important for designing clinical trials. These risks may differ depending on patient age, sex, and type of acute coronary syndrome (ACS). Methods and Result
Externí odkaz:
https://doaj.org/article/53341791bdee457faf2a370c02cfb48a